Update: 13.08.2024
Last week: 31 week 2024 (29.07.2024 - 04.08.2024)
Last full month: July 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 287 | -4.0% | 13.0% | -0.5 | 13 412 804 | -7.4% | 9.0% | -0.8 | 0.1% |
| MoM | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| YTD | 224 366 | 19.5% | 11.5% | 2.6 | 483 375 741 | 39.5% | 9.4% | 2 | -7.9% |
| MAT | 377 462 | 24.4% | 10.6% | 2 | 793 794 139 | 42.8% | 8.8% | 1.5 | 1.1% |
| BRAINMAX | |||||||||
| WoW | 1 001 | -12.1% | 100.0% | 0 | 3 735 888 | -13.1% | 100.0% | 0 | -12.1% |
| MoM | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| YTD | 32 678 | 39.2% | 100.0% | 0 | 119 536 531 | 51.0% | 100.0% | 0 | 39.2% |
| MAT | 55 857 | 66.7% | 100.0% | 0 | 201 386 716 | 80.8% | 100.0% | 0 | 66.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 405 | -1.7% | 46.5% | 0.3 | 44 671 462 | -2.7% | 38.6% | 0.7 | -2.3% |
| MoM | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| YTD | 525 121 | -4.4% | 44.9% | 0.9 | 1 655 174 803 | -1.0% | 36.7% | -2.7 | -6.2% |
| MAT | 845 084 | 3.2% | 45.5% | 1 | 2 675 032 923 | 9.5% | 38.0% | -1.5 | 0.9% |
| MIGRENIUM | |||||||||
| WoW | 10 229 | 4.0% | 0.5% | 0 | 3 482 189 | 4.7% | 0.6% | 0 | -1.5% |
| MoM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| YTD | 363 195 | -6.4% | 0.5% | -0.1 | 112 149 109 | 59.2% | 0.7% | 0.2 | 9.5% |
| MAT | 616 585 | -5.2% | 0.5% | -0.1 | 164 354 141 | 39.1% | 0.6% | 0.1 | 13.0% |
| MODELAX-N | |||||||||
| WoW | 20 849 | -9.7% | 17.6% | -1.1 | 9 870 299 | -8.7% | 11.7% | -1 | -4.1% |
| MoM | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| YTD | 910 541 | 34.7% | 23.0% | 4.2 | 391 115 787 | 83.9% | 14.8% | 4.3 | 10.1% |
| MAT | 1 402 619 | 57.6% | 21.1% | 5.5 | 561 190 853 | 96.8% | 13.0% | 4.2 | 16.6% |
| REDUXIN | |||||||||
| WoW | 9 957 | -6.1% | 32.1% | -1.3 | 50 201 209 | -8.8% | 43.4% | -2.1 | -2.3% |
| MoM | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| YTD | 384 672 | -8.7% | 32.9% | -0.9 | 2 062 197 053 | 14.4% | 45.8% | 3.3 | -6.2% |
| MAT | 601 169 | -4.3% | 32.4% | -1.8 | 3 132 478 430 | 18.4% | 44.4% | 1.7 | 0.9% |
| REDUXIN FORTE | |||||||||
| WoW | 2 923 | 0.0% | 9.4% | 0.2 | 12 476 620 | 1.7% | 10.8% | 0.7 | -2.3% |
| MoM | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| YTD | 102 833 | 0.2% | 8.8% | 0.6 | 445 671 468 | 14.2% | 9.9% | 0.7 | -6.2% |
| MAT | 166 218 | 11.9% | 8.9% | 0.9 | 709 005 730 | 24.8% | 10.1% | 0.9 | 0.9% |
| SALVISAR | |||||||||
| WoW | 7 751 | -2.4% | 1.1% | 0 | 3 466 633 | -2.4% | 1.0% | 0 | 0.7% |
| MoM | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
| YTD | 310 935 | 1.6% | 1.4% | 0 | 126 431 641 | 27.0% | 1.2% | 0.1 | -1.2% |
| MAT | 503 167 | -12.0% | 1.3% | -0.2 | 190 624 265 | -0.8% | 1.1% | -0.2 | 3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 224 366 | 19.5% | 11.5% | 2.6 | 483 375 741 | 39.5% | 9.4% | 2 | -7.9% |
| BRAINMAX | 32 678 | 39.2% | 100.0% | 0 | 119 536 531 | 51.0% | 100.0% | 0 | 39.2% |
| GOLDLINE PLUS | 525 121 | -4.4% | 44.9% | 0.9 | 1 655 174 803 | -1.0% | 36.7% | -2.7 | -6.2% |
| MIGRENIUM | 363 195 | -6.4% | 0.5% | -0.1 | 112 149 109 | 59.2% | 0.7% | 0.2 | 9.5% |
| MODELAX-N | 910 541 | 34.7% | 23.0% | 4.2 | 391 115 787 | 83.9% | 14.8% | 4.3 | 10.1% |
| REDUXIN CAPS | 384 672 | -8.7% | 32.9% | -0.9 | 2 062 197 053 | 14.4% | 45.8% | 3.3 | -6.2% |
| REDUXIN FORTE | 102 833 | 0.2% | 8.8% | 0.6 | 445 671 468 | 14.2% | 9.9% | 0.7 | -6.2% |
| SALVISAR | 310 935 | 1.6% | 1.4% | 0 | 126 431 641 | 27.0% | 1.2% | 0.1 | -1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 377 462 | 24.4% | 10.6% | 2 | 793 794 139 | 42.8% | 8.8% | 1.5 | 1.1% |
| BRAINMAX | 55 857 | 66.7% | 100.0% | 0 | 201 386 716 | 80.8% | 100.0% | 0 | 66.7% |
| GOLDLINE PLUS | 845 084 | 3.2% | 45.5% | 1 | 2 675 032 923 | 9.5% | 38.0% | -1.5 | 0.9% |
| MIGRENIUM | 616 585 | -5.2% | 0.5% | -0.1 | 164 354 141 | 39.1% | 0.6% | 0.1 | 13.0% |
| MODELAX-N | 1 402 619 | 57.6% | 21.1% | 5.5 | 561 190 853 | 96.8% | 13.0% | 4.2 | 16.6% |
| REDUXIN CAPS | 601 169 | -4.3% | 32.4% | -1.8 | 3 132 478 430 | 18.4% | 44.4% | 1.7 | 0.9% |
| REDUXIN FORTE | 166 218 | 11.9% | 8.9% | 0.9 | 709 005 730 | 24.8% | 10.1% | 0.9 | 0.9% |
| SALVISAR | 503 167 | -12.0% | 1.3% | -0.2 | 190 624 265 | -0.8% | 1.1% | -0.2 | 3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 287 | -4.0% | 13.0% | -0.5 | 13 412 804 | -7.4% | 9.0% | -0.8 | 0.1% |
| BRAINMAX | 1 001 | -12.1% | 100.0% | 0 | 3 735 888 | -13.1% | 100.0% | 0 | -12.1% |
| GOLDLINE PLUS | 14 405 | -1.7% | 46.5% | 0.3 | 44 671 462 | -2.7% | 38.6% | 0.7 | -2.3% |
| MIGRENIUM | 10 229 | 4.0% | 0.5% | 0 | 3 482 189 | 4.7% | 0.6% | 0 | -1.5% |
| MODELAX-N | 20 849 | -9.7% | 17.6% | -1.1 | 9 870 299 | -8.7% | 11.7% | -1 | -4.1% |
| REDUXIN CAPS | 9 957 | -6.1% | 32.1% | -1.3 | 50 201 209 | -8.8% | 43.4% | -2.1 | -2.3% |
| REDUXIN FORTE | 2 923 | 0.0% | 9.4% | 0.2 | 12 476 620 | 1.7% | 10.8% | 0.7 | -2.3% |
| SALVISAR | 7 751 | -2.4% | 1.1% | 0 | 3 466 633 | -2.4% | 1.0% | 0 | 0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| BRAINMAX | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| GOLDLINE PLUS | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| MIGRENIUM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| MODELAX-N | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| REDUXIN CAPS | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| REDUXIN FORTE | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| SALVISAR | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs